argenx SE | ARGX - Gross Profit On Sales

Stock Price
657.60
Daily Change
5.60 0.86%
Monthly
-7.41%
Yearly
10.11%
Q1 Forecast
704.56

argenx SE reported $1.14B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
AstraZeneca USD 12.39B 5M Dec/2025
Galapagos EUR -13.57M 74.82M Sep/2025
Genmab DKK 868M 195M Jun/2025
GlaxoSmithKline GBP 6.18B 106M Dec/2025
GRIFOLS EUR 743.8M 49.13M Jun/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Qiagen NV USD 325.27M 19.53M Dec/2025
UCB EUR 2.46B 520M Dec/2024